Nuvation Bio Inc Warrants
NUVB.WS
NUVB.WS was delisted on the 10th of February, 2026.
21 hedge funds and large institutions have $3.26M invested in Nuvation Bio Inc Warrants in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 21 → 21 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.19% less ownership
Funds ownership: 2.08% → 1.89% (-0.19%)
4% less capital invested
Capital invested by funds: $3.39M → $3.26M (-$133K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCA
Octagon Capital Advisors
New York
|
+$54.7K |
| 2 |
IP
Intellectus Partners
San Francisco,
California
|
+$3.92K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.63K |
| 4 |
CAC
Cowen and Company
New York
|
+$18 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$19.8K |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$10.7K |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$1.94K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$654 |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$61 |
NUVB.WS Hedge Fund Activity: Q3 2024 in Review
21 of the 6,981 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q3 2024, worth a combined $3.26M — down 3.9% from $3.39M a quarter earlier.
Fund positioning in NUVB.WS was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was Octagon Capital Advisors, opening a new position worth an estimated $54.7K. The largest seller was 683 Capital Management, cutting an estimated $19.8K.
- 21 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $3.26M of Nuvation Bio Inc Warrants stock for Q3 2024, down 3.9% quarter-over-quarter.
- 2 funds opened new Nuvation Bio Inc Warrants positions in Q3 2024 and 2 closed out, a net change of 0 holders.
- The largest Nuvation Bio Inc Warrants buyer in Q3 2024 was Octagon Capital Advisors, an estimated $54.7K added.
- The largest Nuvation Bio Inc Warrants seller in Q3 2024 was 683 Capital Management, an estimated $19.8K sold.
Based on aggregated 13F filings for Q3 2024.